- Location
new once daily
"-
Novo Nordisk Has Received an Approval of The Price From Chuikyo
Feb 19, 2013Novo Nordisk has received an approval of the price from Japan's Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare, and is set to launch Tresiba (insulin degludec) in ...
Tags: diabetes therapy, Medical, Novo Nordisk
-
Aubagio Has Shown Significant Efficacy Across Key Measures of MS Disease Activity
Dec 5, 2012The FDA has approved Genzyme, a Sanofi company, Aubagio (teriflunomide) as a new once-daily, oral treatment indicated for relapsing forms of multiple sclerosis (MS). Aubagio, an immunomodulator with anti-inflammatory properties, has shown ...
Tags: Aubagio, teriflunomide, new once-daily, oral treatment
-
Supernus Pharmaceuticals Has Received Approval From The FDA for Its Oxtellar XR
Dec 4, 2012Supernus Pharmaceuticals has received approval from the FDA for its Oxtellar XR, a new once-daily extended release formulation of oxcarbazepine. Oxtellar XR is an antiepileptic drug used as an adjunct therapy to treat partial seizures in ...
Tags: oxcarbazepine, FDA approval, partial seizure, pharmaceutical product
-
Genzyme Multiple Sclerosis Medication Gets Approval in Australia
Nov 27, 2012Australian Therapeutic Goods Administration (TGA) has cleared Genzyme's once daily oral Aubagio 14mg dose for the treatment of relapsing multiple sclerosis (MS). Aubagio, which has anti-inflammatory properties, is expected to minimize ...
